Three and a half years after the pandemic outbreak, now that WHO has formally declared
that the emergency is over, COVID-19 is still a significant global issue. Here, we focus on …

Drug treatment of COVID-19 infection : Current Opinion in Pulmonary Medicine Drug treatment
of COVID-19 infection : Current Opinion in Pulmonary Medicine Log in or Register Subscribe to …

The aim of these guidelines is to update the 2017 clinical practice guideline (CPG) of the
European Society of Intensive Care Medicine (ESICM). The scope of this CPG is limited to …

Background Low-dose corticosteroids have been shown to reduce mortality for patients with
COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation …

Background Low-dose corticosteroids have been shown to reduce mortality for patients with
COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation …

Sepsis is a systemic inflammatory disease caused by severe infections that involves multiple
systemic organs, among which the lung is the most susceptible, leaving patients highly …

Acute respiratory distress syndrome (ARDS) is frequently associated with sepsis. ARDS and
sepsis exhibit a common pathobiology, namely excessive inflammation. Corticosteroids are …

The wide and rapid spread of the COVID-19 pandemic has placed an unanticipated burden
on the global healthcare sector. This necessitated a swift response from the international …

Background Management of drug–drug interactions (DDIs) for ensitrelvir, a novel 3-
chymotrypsin-like protease inhibitor of SARS-CoV-2 infection is crucial. A previous clinical …

Background Dexamethasone 6 mg daily for 10 days is the recommended treatment for
patients with severe or critical coronavirus disease 2019 (COVID-19). The evidence on the …